Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance.
Naschitz, J E, Sabo, E, Naschitz, S et al. · Seminars in arthritis and rheumatism · 2001 · DOI
Quick Summary
This study tested how the body's blood pressure and heart rate respond when patients stand up from lying down (a tilt test). Researchers found that people with ME/CFS have much more unstable cardiovascular responses compared to healthy people and those with other conditions. A mathematical score called the hemodynamic instability score (HIS) could correctly identify ME/CFS patients 97% of the time, suggesting this test might help doctors diagnose the condition.
Why It Matters
ME/CFS lacks objective diagnostic biomarkers, making diagnosis difficult and delayed. This study suggests that hemodynamic instability during postural challenge could serve as an objective, quantifiable marker to support ME/CFS diagnosis and may help differentiate it from other conditions, potentially improving clinical recognition and reducing diagnostic uncertainty.
Observed Findings
Mean hemodynamic instability score (HIS) was +3.72 in ME/CFS patients versus -4.62 in healthy controls, with substantial separation between groups.
A cutoff HIS value of -0.98 achieved 97% sensitivity and 97% specificity for differentiating ME/CFS from healthy controls.
HIS differed significantly between ME/CFS and fibromyalgia (p<0.0001) and between ME/CFS and hypertension (p<0.0001), but not between ME/CFS and generalized anxiety disorder (p>0.05).
Fractal dimension of systolic blood pressure changes, systolic BP standard deviation, and heart rate standard deviation were the three independent predictors of ME/CFS status.
Mean HIS values across groups: CFS +3.72 (SD 5.02), fibromyalgia -3.27 (2.63), hypertension -5.53 (2.24), and generalized anxiety disorder +1.08 (5.2).
Inferred Conclusions
Hemodynamic instability during postural challenge is a characteristic feature of ME/CFS that can be quantified objectively using mathematical analysis of blood pressure and heart rate variability.
A derived hemodynamic instability score can reliably identify ME/CFS patients with high sensitivity and specificity, potentially supporting objective diagnosis.
Hemodynamic instability may help differentiate ME/CFS from other conditions, though it cannot reliably distinguish ME/CFS from generalized anxiety disorder.
Remaining Questions
Why does the hemodynamic instability score fail to differentiate ME/CFS from generalized anxiety disorder, and what does this suggest about the shared pathophysiology or confounding factors?
What This Study Does Not Prove
This study does not prove that hemodynamic instability causes ME/CFS or explains the underlying disease mechanism. The cross-sectional design cannot establish whether this instability develops before symptom onset or results from the disease itself. Additionally, the failure to distinguish ME/CFS from generalized anxiety disorder suggests the test may not be specific enough for independent clinical use.
Tags
Symptom:Orthostatic IntoleranceFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does hemodynamic instability persist over time in the same patients, or does it fluctuate with disease severity and symptom status?
What is the underlying physiological mechanism causing this hemodynamic instability in ME/CFS—autonomic nervous system dysfunction, cardiac pump dysfunction, or other factors?
Can this hemodynamic instability score predict treatment response, disease progression, or long-term outcomes in ME/CFS patients?